Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
$2.64
-4.0%
$1.78
$1.30
$7.00
$146.14M1.622.71 million shs1.23 million shs
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$13.80
-4.4%
$14.53
$12.76
$27.28
$137.39M1.1178,413 shs280,418 shs
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
$1.02
-19.7%
$1.11
$0.73
$1.80
$137.77M1.241.11 million shs6.88 million shs
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
$0.89
-0.6%
$0.79
$0.40
$1.39
$44.68M0.68365,768 shs218,982 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
-4.00%-2.58%+83.33%+26.92%-58.94%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
-4.43%-6.38%+0.29%-10.04%-28.65%
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
-19.69%-17.74%+2.22%-22.14%+27.17%
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
-0.63%+19.39%+20.29%+54.70%+5.71%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
$2.64
-4.0%
$1.78
$1.30
$7.00
$146.14M1.622.71 million shs1.23 million shs
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$13.80
-4.4%
$14.53
$12.76
$27.28
$137.39M1.1178,413 shs280,418 shs
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
$1.02
-19.7%
$1.11
$0.73
$1.80
$137.77M1.241.11 million shs6.88 million shs
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
$0.89
-0.6%
$0.79
$0.40
$1.39
$44.68M0.68365,768 shs218,982 shs
7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
-4.00%-2.58%+83.33%+26.92%-58.94%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
-4.43%-6.38%+0.29%-10.04%-28.65%
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
-19.69%-17.74%+2.22%-22.14%+27.17%
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
-0.63%+19.39%+20.29%+54.70%+5.71%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
2.50
Moderate Buy$8.80233.33% Upside
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
2.75
Moderate Buy$26.0088.41% Upside
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
3.00
Buy$3.65257.84% Upside
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
3.00
Buy$2.23150.56% Upside

Current Analyst Ratings Breakdown

Latest NMTC, LAKE, LUCD, and INO Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/9/2025
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
Maxim Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageBuy$3.00
9/5/2025
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
BTIG Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$2.00 ➝ $2.50
9/3/2025
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeStrong-BuyHold
8/14/2025
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
HC Wainwright
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral$3.00
8/14/2025
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
Zacks Research
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeStrong SellHold
8/13/2025
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$3.00
7/16/2025
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
Needham & Company LLC
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingBuy$3.00
7/9/2025
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
Piper Sandler
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Initiated CoverageOverweight$5.00
(Data available from 9/11/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
$220K637.68N/AN/A$1.90 per share1.39
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$167.21M0.78$1.02 per share13.53$15.44 per share0.89
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
$4.35M25.44N/AN/A($0.78) per share-1.31
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
$3.45M12.87N/AN/A$0.03 per share29.60
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
-$107.25M-$2.61N/AN/AN/AN/A-163.32%-96.41%11/13/2025 (Estimated)
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
-$18.08M-$3.01N/A8.31N/A-11.22%-3.12%-2.05%N/A
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
-$45.53M-$1.19N/AN/AN/A-1,476.35%N/A-120.43%11/12/2025 (Estimated)
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
-$12.32M-$0.15N/AN/A-55.44%-163.49%-78.67%N/A

Latest NMTC, LAKE, LUCD, and INO Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
9/9/2025Q2 2026
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
-$0.04$0.36+$0.40$0.08$54.59 million$52.50 million
8/14/2025Q3 2025
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
-$0.05-$0.03+$0.02-$0.03$1.82 million$1.70 million
8/12/2025Q2 2025
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
-$0.63-$0.61+$0.02-$0.61$0.01 millionN/A
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
N/AN/AN/AN/AN/A
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
$0.120.87%N/AN/A 1 Years
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
N/AN/AN/AN/AN/A
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
N/AN/AN/AN/AN/A

Latest NMTC, LAKE, LUCD, and INO Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
8/1/2025
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
quarterly$0.030.9%8/15/20258/15/20258/22/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
N/A
1.66
1.66
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
0.17
3.88
1.51
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
N/A
1.15
1.13
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
N/A
7.13
5.80

Institutional Ownership

CompanyInstitutional Ownership
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
26.79%
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
71.69%
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
74.01%
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
16.07%
CompanyEmployeesShares OutstandingFree FloatOptionable
Inovio Pharmaceuticals, Inc. stock logo
INO
Inovio Pharmaceuticals
32053.14 million51.92 millionOptionable
Lakeland Industries, Inc. stock logo
LAKE
Lakeland Industries
2,1009.51 million9.33 millionOptionable
Lucid Diagnostics Inc. stock logo
LUCD
Lucid Diagnostics
70108.48 million101.10 millionNo Data
NeuroOne Medical Technologies Corporation stock logo
NMTC
NeuroOne Medical Technologies
2050.00 million45.55 millionOptionable

Recent News About These Companies

NeuroOne Medical Technologies Corporation (NASDAQ:NMTC) Short Interest Update
NeuroOne Q3 Revenue Jumps 105 Percent
NeuroOne Revenue Jumps 105 Percent in Q3

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Inovio Pharmaceuticals stock logo

Inovio Pharmaceuticals NASDAQ:INO

$2.64 -0.11 (-4.00%)
Closing price 09/10/2025 04:00 PM Eastern
Extended Trading
$2.63 -0.01 (-0.38%)
As of 09/10/2025 07:54 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Inovio Pharmaceuticals, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of DNA medicines to treat and protect people from diseases associated with human papillomavirus (HPV), cancer, and infectious diseases. Its DNA medicines platform uses precisely designed SynCon that identify and optimize the DNA sequence of the target antigen, as well as CELLECTRA smart devices technology that facilitates delivery of the DNA plasmids. Its products in pipeline include VGX-3100 for the treatment of HPV-related cervical high-grade dysplasia; INO-3107 for HPV-related recurrent respiratory papillomatosis and is under Phase 1/2 trial; INO-3112 for the treatment of HPV-related Oropharyngeal Squamous Cell Carcinoma and is under Phase 2 trial; INO-5401 for the treatment of glioblastoma multiforme and is under Phase 2 trial; INO-4201 for Ebola Virus Disease and is under Phase 1b trial; INO-4800 for COVID-19 and is under Phase 3 trial; and INO-6160 for the treatment of human immunodeficiency virus and is under Phase 1 trial. Its partners and collaborators include Advaccine Biopharmaceuticals Suzhou Co, ApolloBio Corporation, AstraZeneca, The Bill & Melinda Gates Foundation, Coalition for Epidemic Preparedness Innovations, Defense Advanced Research Projects Agency, The U.S. Department of Defense, HIV Vaccines Trial Network, International Vaccine Institute, Kaneka Eurogentec, National Cancer Institute, National Institutes of Health, National Institute of Allergy and Infectious Diseases, the Parker Institute for Cancer Immunotherapy, Plumbline Life Sciences, Regeneron Pharmaceuticals, Richter-Helm BioLogics, Thermo Fisher Scientific, the University of Pennsylvania, the Walter Reed Army Institute of Research, and The Wistar Institute. The company was incorporated in 1983 and is headquartered in Plymouth Meeting, Pennsylvania.

Lakeland Industries stock logo

Lakeland Industries NASDAQ:LAKE

$13.80 -0.64 (-4.43%)
Closing price 09/10/2025 04:00 PM Eastern
Extended Trading
$13.81 +0.01 (+0.07%)
As of 09/10/2025 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lakeland Industries, Inc. manufactures and sells industrial protective clothing and accessories for the industrial and public protective clothing market worldwide. It offers firefighting and heat protective apparel to protect against fire; high-end chemical protective suits to provide protection from highly concentrated, toxic and/or lethal chemicals, and biological toxins; and limited use/disposable protective clothing, such as coveralls, laboratory coats, shirts, pants, hoods, aprons, sleeves, arm guards, caps, and smocks. The company provides durable woven garments, including electrostatic dissipative apparel used in electronics clean rooms; flame resistant meta aramid, para aramid, and FR cotton coveralls/pants/jackets used in petrochemical, refining operations, and electrical utilities; FR fabrics; and cotton and polycotton coveralls, lab coats, pants, and shirts. In addition, it provides high visibility clothing comprising reflective apparel, including vests, T-shirts, sweatshirts, jackets, coats, raingear, jumpsuits, hats, and gloves; and gloves and sleeves that are used in the automotive, glass, and metal fabrication industries. The company sells its products to a network of safety and industrial supply distributors through in-house sales teams, customer service group, and independent sales representatives. It serves end users, such as integrated oil, chemical/petrochemical, automobile, steel, glass, construction, smelting, cleanroom, janitorial, pharmaceutical, and high technology electronics manufacturers, as well as scientific, medical laboratories, and the utilities industry; and federal, state, and local governmental agencies and departments. Lakeland Industries, Inc. was incorporated in 1982 and is headquartered in Huntsville, Alabama.

Lucid Diagnostics stock logo

Lucid Diagnostics NASDAQ:LUCD

$1.02 -0.25 (-19.69%)
Closing price 09/10/2025 04:00 PM Eastern
Extended Trading
$1.06 +0.04 (+3.92%)
As of 09/10/2025 07:26 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with the EsoCheck Esophageal Cell collection device, a testing tool with the goal of preventing EAC deaths through early detection of esophageal precancer in at-risk GERD patients. The company was incorporated in 2018 and is based in New York, New York. Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc.

NeuroOne Medical Technologies stock logo

NeuroOne Medical Technologies NASDAQ:NMTC

$0.89 -0.01 (-0.63%)
Closing price 09/10/2025 04:00 PM Eastern
Extended Trading
$0.89 +0.01 (+0.68%)
As of 09/10/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NeuroOne Medical Technologies Corporation, a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.